Mayo Clinic and National Decision Support Company unveil CareSelect Lab™ to provide real-time medical guidance when ordering clinical lab tests. The tool assists health care providers with appropriate ordering of lab testing, improving patient care and reducing wasteful spending.
This week’s Research Roundup highlights Mayo Clinic researchers who conducted a study to characterize the clinical, pathologic, and survival implications of non-V600 BRAF mutations in metastatic colorectal cancer.
This week’s Research Roundup highlights autologous mesenchymal stem cells, applied in a bioabsorbable matrix, for treatment of perianal fistulas in patients with Crohn's disease.
This week’s Research Roundup highlights individual patient-level meta-analysis of the performance of the Decipher genomic classifier in high-risk men after prostatectomy to predict development of metastatic disease.
This week’s Research Roundup highlights a review of how to treat autoimmune hemolytic anemia.
This week’s Research Roundup highlights how intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation.
Researchers from Mayo Clinic and the Johns Hopkins University School of Medicine published an article in "JAMA Internal Medicine" outlining the elimination from clinical practice of a popular test for diagnosing heart attacks.
This week’s Research Roundup highlights how human gut-derived commensal bacteria suppresses central nervous system inflammatory and demyelinating disease.
This week’s Research Roundup highlights a randomized controlled trial of postoperative belladonna and opium rectal suppositories in vaginal surgery.
This week’s Research Roundup highlights urinary extracellular vesicles of podocyte origin and renal injury in preeclampsia.
This week’s Research Roundup highlights renal allograft histology at 10 years after transplantation in the tacrolimus era and evidence of pervasive chronic injury.
Sudden cardiac death and episodes of fainting and seizures from long QT syndrome are significantly lower than previously thought when patients are diagnosed and treated at a specialty center dedicated to the treatment of genetic heart rhythm diseases, according to Mayo Clinic research published in the Journal of the American College of Cardiology.
This week’s Research Roundup highlights postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease.